Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis

Clinical and Experimental Allergy

Volumn 36, Issue 10, 2006, Pages 1260-1267

  Sena, A A S ^a   Provazzi, P J S ^c   Fernandes, A M ^b   Cury, P M ^b   Rahal, P ^c   Oliani, S M ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculty of Medicine   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Annexin 1; Epithelial cells; Galectin 1; Glucocorticoid; Inflammatory cells; Nasal polyp

Indexed keywords

ANNEXIN; ANNEXIN 1; BETAMETHASONE; GALECTIN 1; GLUCOCORTICOID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MAST CELL; NOSE MUCOSA; NOSE POLYP; NOSE SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL TECHNIQUE; ULTRASTRUCTURE; UPREGULATION; WESTERN BLOTTING;

ADULT; ANNEXIN A1; BLOTTING, WESTERN; EOSINOPHILS; FEMALE; GALECTIN 1; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; NASAL MUCOSA; NASAL POLYPS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33749370699     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02570.x     Document Type: Article

References (35)

1. Bachert C, Gevaert P, Holtappels G, Van Cauwenberg P. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2002; 2:81-7.
2. Pawankar R. Nasal polyposis: an update editorial review. Curr Opin Allergy Clin Immunol 2003; 3:1-6.
3. Bachert C, Wagenmann M, Rudack C et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998; 53:2-13.
4. Lee CH, Lee KS, Rhee CS, Lee SO, Min YG. Distribution of rantes and interleukin-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1999; 108:594-8.
5. Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 2005; 87:111-29.
6. Rodrigo JP, Garcia-Pedrero JM, Gonzalez MV, Fernandez MP, Suarez C, Herrero A. Expression of annexin A1 in normal and chronically inflamed nasal mucosa. Arch Otolaryngol Head Neck Surg 2004; 130:211-5.
7. Delbrouck C, Doyen I, Belot N et al. Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration. Lab Invest 2002; 82:147-58.
8. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82:331-71.
9. Perretti M, Gavins FNE. Annexin 1: an endogenous anti-inflammatory protein. News Physiol Sci 2003; 18:60-4.
10. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res 2004; 53:125-32.
11. Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003; 15:93-107.
12. Goulding NJ, Godolphin JL, Sharland PR et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990; 335:1416-8.
13. Perretti M, Flower RJ. Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br J Pharmacol 1996; 118:605-10.
14. Rabinovich GA, Toscano MA, Ilarregui JM, Rubinstein N. Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. Glycoconjugate J 2004; 19:565-73.
15. Oliani SM, Christian HC, Manston J, Flower RJ, Perretti M. An immunocytochemical and in situ hibridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest 2000; 80:1429-38.
16. Oliani SM, Paul-Clark MJ, Christian H, Flower RJ, Perretti M. Neutrophil interaction with inflamed post-capillary venule endothelium alters annexin I expression. Am J Phatol 2001; 158:603-15.
17. Das AM, Lim LHK, Flower RJ, Perretti M. Dexamethasone reduces cell surface levels of CD11b on human eosinophils. Med Inflamm 1997; 6:363-7.
18. Smith SF, Goulding NJ, Godolphin JL et al. An assay for the assessment of lipocortin 1 levels in human lung lavage fluid. J Immunol Methods 1990; 131:119-25.
19. Traverso V, Morris JF, Flower RJ, Buckingham J. Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cell cytoplasm. J Cell Sci 1998; 111:1405-18.
20. Ambrose MP, Bahns CL, Hunninghake GW. Lipocortin I production by human alveolar macrophages. Am J Respir Cell Mol Biol 1992; 6:17-21.
21. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration by dexamethasone. Nat Med 1996; 2:1259-62.
22. Bachert C, Gevaert P, Holtappels G, Johansson SGO, Cauwenberg PV. Total and specific IgE in nasal polyp is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-14.
23. Pawliczak R, Kowalski ML, Danilewicz M, Wagrowska-Danilewicz M, Lewandowski A. Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study. Am J Rhinol 1997; 11:257-62.
24. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997; 123:595-600.
25. Bai XF, Ni XG, Zhao P et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10:1466-70.
26. Masaki T, Tokuda M, Ohnishi M et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24:72-81.
27. Tsao FH, Meyer KC, Chen X, Rosenthal NS, Hu J. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am J Respir Cell Mol Biol 1998; 18:120-8.
28. Harjacek M, Diaz-Cano S, De Miguel M,Wolfe H, Maldonado CA, Rabinovich GA. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J Rheumatol 2001; 28:1914-22.
29. Ahluwalia A, Newbold P, Brain SD, Flower RJ. Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1. Eur J Pharmacol 1995; 283:193-8.
30. Perretti M, Ahluwalia A. The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation 2000; 7:147-61.
31. Ahluwalia A,Mohamed RW, Flower RJ. Induction of lipocortin 1 by topical steroid in rat skin. Biochem Pharmacol 1994; 48:1647-54.
32. Oliani SM, Damazo AS, Perretti M. Annexin 1 localisation in tissue eosinophils as detected by electron microscopy. Mediators Inflamm 2002; 11:287-92.
33. Damazo AS, Paul-Clark MJ, Straus AH, Takahashi HK, Perretti M, Oliani SM. Analysis of the annexin 1 expression in rat trachea: study of the mast cell heterogeneity. Annexins 2004; 1:12-8.
34. Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 2000; 130:289-98.
35. Scott K, Weinberg C. Galectin-1: a bifunctional regulator of cellular proliferation. Glycoconjugate J 2004; 19:467-77.